Children’s National oncology team showcases research and leadership at ASPHO 2026
Children’s National fellows shared their research at ASPHO 2026, contributing to important conversations in pediatric hematology/oncology.
Children’s National Hospital had a strong presence at the 2026 ASPHO Conference, held April 29th – May 2nd in Minneapolis, Minnesota, where pediatric hematology/oncology specialists gathered to share the latest clinical, translational and survivorship research and to advance collaboration across the field. This year’s meeting offered an important platform for Children’s National oncology faculty and fellows to contribute to national conversations through invited presentations, abstract-driven sessions and society leadership roles.
Jennifer Levine, MD, medical director of the Cancer Survivorship Program, presented during the Presidential Symposium, “Addressing Financial Distress in Pediatric Hematology/Oncology: Implications for Cancer, Sickle Cell Disease, and Survivorship.” Her talk, “The Financial Burden of Fertility Preservation among CAYA with Cancer,” highlighted an important dimension of survivorship care and reflected Children’s National Hospital’s commitment to advancing patient-centered oncology research.
Lea Mayer, DNP, APRN, CPNP-PC, CPHON, pediatric nurse practitioner, was named chair of the ASPHO Advanced Practice Provider Special Interest Group and contributed as a panel expert and poster co-presenter.
Liny John, MD, MSE, MHS, represented Children’s National in ASPHO leadership through service on the Education Committee and as chair of the Accreditation Sub-Committee.
Children’s National fellows also contributed to the scientific program. Alan Siegel, MD, received an Early Career Travel Award and delivered a platform presentation on immune subset dynamics following selumetinib treatment for NF1 plexiform neurofibromas. Anisha Gopu-Gilboy, MD and Audrey Ward, MD presented posters that further showcased the breadth of fellow-led clinical scholarship at Children’s National.
By sharing expertise on a national stage, the oncology team is helping shape the future of the field and reinforcing leadership in research, education and innovation at Children’s National.
